Guideline Directed Medical Therapy

DRUG4 trials

Sponsors

Edwards Lifesciences, Hospices Civils de Lyon, Samsung Medical Center, Shanghai Huihe Medical Technology Co., Ltd

Conditions

Coronary Artery DiseaseEnd-stage Heart FailureFunctional Mitral RegurgitationMitral InsufficiencyMitral RegurgitationSevere or Greater Tricuspid Regurgitation

Unknown Phase

Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

TerminatedNCT03016975

Edwards LifesciencesFunctional Mitral Regurgitation, Mitral Insufficiency, Mitral Regurgitation

Start: 2017-06-01End: 2022-09-20Updated: 2023-11-30

LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

RecruitingNCT04768322

Hospices Civils de LyonEnd-stage Heart Failure

Start: 2021-02-24End: 2029-02-01Target: 92Updated: 2026-05-08

Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.

RecruitingNCT07068490

Samsung Medical CenterCoronary Artery Disease

Start: 2024-10-22End: 2025-12-31Target: 100000Updated: 2025-07-16

A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.

RecruitingNCT07433504

Shanghai Huihe Medical Technology Co., LtdSevere or Greater Tricuspid Regurgitation

Start: 2026-01-28End: 2031-12-31Target: 132Updated: 2026-02-25